“…It is increasingly evident, that various non-excitable cells, such as alveolar epithelial cells, fibroblasts and immune cells are sensitive to the changes in CO 2 concentrations independently of intra-and extracellular pH, reactive oxygen species (ROS) and involvement of the carbonic anhydrases (Putnam et al, 2004;Shigemura et al, 2017;Cummins et al, 2019). In contrast to earlier reports, which suggested that hypercapnia might be tolerated or even beneficial in the setting of critically ill patients (Fuller et al, 2017;Roberts et al, 2018); more recent studies have shown that elevated CO 2 levels are associated with higher complication rates, increased risk of exacerbations, more severe disease states, worse outcomes and an increased risk of mortality both for acute and chronic lung diseases (Yang et al, 2015;Nin et al, 2017;Husain-Syed et al, 2020;Shigemura et al, 2020). In addition, translational studies established that high CO 2 levels impair alveolar fluid clearance, innate immunity and cellular host defense, decrease cytokine production, downregulate phagocytosis and macrophage activity.…”